Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nuvalent, Inc. (NUVL) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nuvalent, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1861560.
Total stock buying since 2021: $34,270,000.
Total stock sales since 2021: $519,597,439.
Total stock option exercises since 2021: $23,411,747.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 827,212 | $67,125,495 | 794,398 | $15,641,666 |
| 2024 | 0 | $0 | 4,713,129 | $416,846,343 | 305,448 | $5,726,848 |
| 2023 | 0 | $0 | 481,138 | $29,610,739 | 261,138 | $1,884,101 |
| 2022 | 650,000 | $21,775,000 | 227,400 | $6,014,862 | 58,513 | $159,132 |
| 2021 | 735,000 | $12,495,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-10 | 0 | $0 | 145,958 | $13,034,811 | 145,958 | $2,594,408 |
| 2025-09 | 0 | $0 | 116,313 | $9,394,672 | 116,313 | $1,929,314 |
| 2025-08 | 0 | $0 | 36,500 | $2,763,925 | 41,507 | $766,926 |
| 2025-07 | 0 | $0 | 246,645 | $20,644,796 | 244,500 | $4,699,485 |
| 2025-06 | 0 | $0 | 62,000 | $4,881,966 | 62,000 | $1,556,439 |
| 2025-05 | 0 | $0 | 31,000 | $2,176,191 | 31,000 | $836,450 |
| 2025-04 | 0 | $0 | 31,000 | $2,175,685 | 31,000 | $809,550 |
| 2025-03 | 0 | $0 | 65,000 | $4,787,330 | 65,000 | $942,480 |
| 2025-02 | 0 | $0 | 29,000 | $2,282,329 | 27,000 | $751,950 |
| 2025-01 | 0 | $0 | 63,796 | $4,983,790 | 30,120 | $754,664 |
| 2024-12 | 0 | $0 | 1,277,000 | $112,341,170 | 73,114 | $828,758 |
| 2024-11 | 0 | $0 | 44,000 | $3,986,275 | 42,000 | $1,102,450 |
| 2024-10 | 0 | $0 | 2,039,000 | $199,352,285 | 37,000 | $1,030,450 |
| 2024-09 | 0 | $0 | 60,795 | $5,903,019 | 26,000 | $545,260 |
| 2024-08 | 0 | $0 | 39,834 | $3,333,628 | 27,334 | $602,435 |
| 2024-07 | 0 | $0 | 21,000 | $1,643,760 | 19,000 | $351,370 |
| 2024-06 | 0 | $0 | 25,000 | $1,935,303 | 23,000 | $450,730 |
| 2024-05 | 0 | $0 | 85,000 | $5,794,606 | 8,000 | $78,545 |
| 2024-04 | 0 | $0 | 160,000 | $10,656,765 | 8,000 | $67,470 |
| 2024-03 | 0 | $0 | 961,500 | $71,899,532 | 42,000 | $669,380 |
| 2023-12 | 0 | $0 | 232,196 | $17,512,622 | 113,046 | $1,392,461 |
| 2023-11 | 0 | $0 | 12,150 | $724,467 | 3,000 | $3,240 |
| 2023-10 | 0 | $0 | 122,695 | $6,377,954 | 30,995 | $138,025 |
| 2023-09 | 0 | $0 | 5,000 | $234,890 | 5,000 | $17,020 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-10-20 | Miller Deborah Ann (Chief Legal Officer) | Sale | 5,000 | 94.91 | 474,550 |
| 2025-10-20 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 5,000 | 6.89 | 34,450 |
| 2025-10-16 | Miller Deborah Ann (Chief Legal Officer) | Sale | 12,376 | 91.47 | 1,132,032 |
| 2025-10-16 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 12,376 | 6.89 | 85,270 |
| 2025-10-16 | Porter James Richard (President and CEO) | Sale | 27,000 | 91.44 | 2,468,745 |
| 2025-10-16 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 18.93 | 511,110 |
| 2025-10-15 | Pelish Henry E. (Chief Scientific Officer) | Sale | 14,205 | 90.04 | 1,279,018 |
| 2025-10-15 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 14,205 | 39.71 | 564,080 |
| 2025-10-15 | Miller Deborah Ann (Chief Legal Officer) | Sale | 15,624 | 89.98 | 1,405,847 |
| 2025-10-15 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 15,624 | 6.89 | 107,649 |
| 2025-10-15 | Balcom Alexandra (Chief Financial Officer) | Sale | 1,683 | 85.57 | 144,014 |
| 2025-10-15 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 1,683 | 18.93 | 31,859 |
| 2025-10-14 | Pelish Henry E. (Chief Scientific Officer) | Sale | 2,433 | 86.16 | 209,627 |
| 2025-10-14 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 2,433 | 25.37 | 61,725 |
| 2025-10-14 | Balcom Alexandra (Chief Financial Officer) | Sale | 20,000 | 87.24 | 1,744,760 |
| 2025-10-14 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 20,000 | 18.93 | 378,600 |
| 2025-10-13 | Pelish Henry E. (Chief Scientific Officer) | Sale | 7,637 | 89.81 | 685,878 |
| 2025-10-13 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 7,637 | 39.71 | 303,265 |
| 2025-10-13 | Balcom Alexandra (Chief Financial Officer) | Sale | 20,000 | 88.62 | 1,772,340 |
| 2025-10-13 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 20,000 | 12.91 | 258,200 |
| 2025-10-01 | Balcom Alexandra (Chief Financial Officer) | Sale | 20,000 | 85.90 | 1,718,000 |
| 2025-10-01 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 20,000 | 12.91 | 258,200 |
| 2025-09-30 | Balcom Alexandra (Chief Financial Officer) | Sale | 20,000 | 85.06 | 1,701,200 |
| 2025-09-30 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 20,000 | 6.89 | 137,800 |
| 2025-09-29 | Noci Darlene (Chief Development Officer) | Sale | 4,000 | 83.27 | 333,096 |
| 2025-09-29 | Noci Darlene (Chief Development Officer) | Option Ex | 4,000 | 27.85 | 111,400 |
| 2025-09-29 | Balcom Alexandra (Chief Financial Officer) | Sale | 7,588 | 85.01 | 645,055 |
| 2025-09-29 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 7,588 | 6.89 | 52,281 |
| 2025-09-15 | Porter James Richard (President and CEO) | Sale | 54,000 | 79.28 | 4,281,120 |
| 2025-09-15 | Porter James Richard (President and CEO) | Option Ex | 54,000 | 18.93 | 1,022,220 |
| 2025-09-10 | Pelish Henry E. (Chief Scientific Officer) | Sale | 3,725 | 78.83 | 293,641 |
| 2025-09-10 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 3,725 | 25.37 | 94,503 |
| 2025-08-29 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 5,007 | .97 | 4,881 |
| 2025-08-25 | Noci Darlene (Chief Development Officer) | Sale | 4,000 | 74.84 | 299,360 |
| 2025-08-25 | Noci Darlene (Chief Development Officer) | Option Ex | 4,000 | 27.85 | 111,400 |
| 2025-08-15 | Porter James Richard (President and CEO) | Sale | 27,000 | 76.03 | 2,052,891 |
| 2025-08-15 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 18.93 | 511,110 |
| 2025-08-07 | Pelish Henry E. (Chief Scientific Officer) | Sale | 5,500 | 74.85 | 411,674 |
| 2025-08-07 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 5,500 | 25.37 | 139,535 |
| 2025-07-30 | Noci Darlene (Chief Development Officer) | Sale | 4,000 | 80.36 | 321,440 |
| 2025-07-30 | Noci Darlene (Chief Development Officer) | Option Ex | 4,000 | 27.85 | 111,400 |
| 2025-07-16 | Balcom Alexandra (Chief Financial Officer) | Sale | 44,100 | 85.10 | 3,752,910 |
| 2025-07-16 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 44,100 | 18.93 | 834,813 |
| 2025-07-15 | Porter James Richard (President and CEO) | Sale | 81,000 | 83.11 | 6,731,505 |
| 2025-07-15 | Porter James Richard (President and CEO) | Option Ex | 81,000 | 18.93 | 1,533,330 |
| 2025-07-15 | Balcom Alexandra (Chief Financial Officer) | Sale | 15,900 | 84.23 | 1,339,302 |
| 2025-07-15 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 15,900 | 18.93 | 300,987 |
| 2025-07-10 | Pelish Henry E. (Chief Scientific Officer) | Sale | 5,500 | 80.43 | 442,365 |
| 2025-07-10 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 5,500 | 25.37 | 139,535 |
| 2025-07-09 | Pelish Henry E. (Chief Scientific Officer) | Sale | 2,145 | 81.49 | 174,796 |
| 2025-06-27 | Pelish Henry E. (Chief Scientific Officer) | Sale | 2,170 | 79.92 | 173,426 |
| 2025-06-27 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 2,170 | 28.59 | 62,040 |
| 2025-06-27 | Balcom Alexandra (Chief Financial Officer) | Sale | 20,000 | 80.02 | 1,600,400 |
| 2025-06-27 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 20,000 | 18.93 | 378,600 |
| 2025-06-26 | Noci Darlene (Chief Development Officer) | Sale | 4,000 | 78.41 | 313,640 |
| 2025-06-26 | Noci Darlene (Chief Development Officer) | Option Ex | 4,000 | 27.85 | 111,400 |
| 2025-06-25 | Pelish Henry E. (Chief Scientific Officer) | Sale | 8,630 | 79.87 | 689,278 |
| 2025-06-25 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 8,630 | 28.59 | 246,731 |
| 2025-06-16 | Porter James Richard (President and CEO) | Sale | 27,000 | 77.38 | 2,089,259 |
| 2025-06-16 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 27.85 | 751,950 |
| 2025-06-06 | Pelish Henry E. (Chief Scientific Officer) | Sale | 200 | 79.82 | 15,963 |
| 2025-06-06 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 200 | 28.59 | 5,718 |
| 2025-05-29 | Noci Darlene (Chief Development Officer) | Sale | 4,000 | 71.46 | 285,840 |
| 2025-05-29 | Noci Darlene (Chief Development Officer) | Option Ex | 4,000 | 21.12 | 84,500 |
| 2025-05-15 | Porter James Richard (President and CEO) | Sale | 27,000 | 70.01 | 1,890,351 |
| 2025-05-15 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 27.85 | 751,950 |
| 2025-04-29 | Noci Darlene (Chief Development Officer) | Sale | 4,000 | 74.56 | 298,240 |
| 2025-04-29 | Noci Darlene (Chief Development Officer) | Option Ex | 4,000 | 14.40 | 57,600 |
| 2025-04-15 | Porter James Richard (President and CEO) | Sale | 27,000 | 69.53 | 1,877,445 |
| 2025-04-15 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 27.85 | 751,950 |
| 2025-03-27 | Noci Darlene (Chief Development Officer) | Sale | 4,000 | 73.37 | 293,480 |
| 2025-03-27 | Noci Darlene (Chief Development Officer) | Option Ex | 4,000 | 16.66 | 66,660 |
| 2025-03-17 | Porter James Richard (President and CEO) | Sale | 27,000 | 76.06 | 2,053,620 |
| 2025-03-17 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 27.85 | 751,950 |
| 2025-03-07 | Noci Darlene (Chief Development Officer) | Sale | 4,000 | 72.14 | 288,540 |
| 2025-03-07 | Noci Darlene (Chief Development Officer) | Option Ex | 4,000 | 1.08 | 4,320 |
| 2025-03-06 | Noci Darlene (Chief Development Officer) | Sale | 30,000 | 71.72 | 2,151,690 |
| 2025-03-06 | Noci Darlene (Chief Development Officer) | Option Ex | 30,000 | 3.98 | 119,550 |
| 2025-02-24 | Shair Matthew | Sale | 2,000 | 78.38 | 156,754 |
| 2025-02-18 | Porter James Richard (President and CEO) | Sale | 27,000 | 78.72 | 2,125,575 |
| 2025-02-18 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 27.85 | 751,950 |
| 2025-01-31 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 3,120 | .87 | 2,714 |
| 2025-01-27 | Shair Matthew | Sale | 2,000 | 83.51 | 167,016 |
| 2025-01-15 | Porter James Richard (President and CEO) | Sale | 27,000 | 76.09 | 2,054,565 |
| 2025-01-15 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 27.85 | 751,950 |
| 2025-01-06 | Pelish Henry E. (Chief Scientific Officer) | Sale | 2,483 | 79.38 | 197,107 |
| 2025-01-06 | Miller Deborah Ann (Chief Legal Officer) | Sale | 2,964 | 79.38 | 235,291 |
| 2025-01-06 | Porter James Richard (President and CEO) | Sale | 17,301 | 79.38 | 1,373,405 |
| 2025-01-06 | Noci Darlene (Chief Development Officer) | Sale | 4,016 | 79.38 | 318,802 |
| 2025-01-06 | Balcom Alexandra (Chief Financial Officer) | Sale | 4,016 | 79.38 | 318,802 |
| 2025-01-06 | Turner Christopher Durant (Chief Medical Officer) | Sale | 4,016 | 79.38 | 318,802 |
| 2024-12-19 | Porter James Richard (President and CEO) | Option Ex | 22,000 | .65 | 14,300 |
| 2024-12-17 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 13,700 | 3.98 | 54,594 |
| 2024-12-16 | Pelish Henry E. (Chief Scientific Officer) | Option Ex | 10,414 | .76 | 7,914 |
| 2024-12-16 | Porter James Richard (President and CEO) | Sale | 27,000 | 86.71 | 2,341,170 |
| 2024-12-16 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 27.85 | 751,950 |
| 2024-12-11 | Hack Andrew A. F. | Sale | 1,250,000 | 88.00 | 110,000,000 |
| 2024-11-29 | Balcom Alexandra (Chief Financial Officer) | Sale | 10,000 | 95.97 | 959,700 |
| 2024-11-29 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 10,000 | 27.85 | 278,500 |
| 2024-11-25 | Shair Matthew | Sale | 2,000 | 96.60 | 193,200 |
| 2024-11-15 | Porter James Richard (President and CEO) | Sale | 27,000 | 88.47 | 2,388,690 |
| 2024-11-15 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 27.85 | 751,950 |
| 2024-11-01 | Noci Darlene (Chief Development Officer) | Sale | 5,000 | 88.94 | 444,685 |
| 2024-11-01 | Noci Darlene (Chief Development Officer) | Option Ex | 5,000 | 14.40 | 72,000 |
| 2024-10-31 | Balcom Alexandra (Chief Financial Officer) | Sale | 10,000 | 89.67 | 896,680 |
| 2024-10-31 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 10,000 | 27.85 | 278,500 |
| 2024-10-28 | Shair Matthew | Sale | 2,000 | 92.23 | 184,460 |
| 2024-10-22 | Deerfield Private Design Fund Iv, L.p. | Sale | 2,000,000 | 97.75 | 195,500,000 |
| 2024-10-15 | Porter James Richard (President and CEO) | Sale | 27,000 | 102.64 | 2,771,145 |
| 2024-10-15 | Porter James Richard (President and CEO) | Option Ex | 27,000 | 27.85 | 751,950 |
| 2024-09-30 | Balcom Alexandra (Chief Financial Officer) | Sale | 10,000 | 100.50 | 1,004,980 |
| 2024-09-30 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 10,000 | 27.85 | 278,500 |
| 2024-09-23 | Shair Matthew | Sale | 2,000 | 104.43 | 208,860 |
| 2024-09-16 | Pelish Henry E. (Chief Scientific Officer) | Sale | 32,795 | 98.25 | 3,222,272 |
| 2024-09-16 | Miller Deborah Ann (Chief Legal Officer) | Sale | 8,000 | 97.46 | 779,688 |
| 2024-09-16 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 8,000 | 18.93 | 151,440 |
| 2024-09-09 | Miller Deborah Ann (Chief Legal Officer) | Sale | 3,000 | 87.88 | 263,634 |
| 2024-09-09 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 3,000 | 6.89 | 20,670 |
| 2024-09-03 | Noci Darlene (Chief Development Officer) | Sale | 5,000 | 84.72 | 423,585 |
| 2024-09-03 | Noci Darlene (Chief Development Officer) | Option Ex | 5,000 | 18.93 | 94,650 |
| 2024-08-30 | Balcom Alexandra (Chief Financial Officer) | Sale | 10,000 | 84.79 | 847,930 |
| 2024-08-30 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 10,000 | 27.85 | 278,500 |
| 2024-08-26 | Shair Matthew | Sale | 2,000 | 84.71 | 169,420 |
| 2024-08-23 | Pelish Henry E. (Chief Scientific Officer) | Sale | 10,500 | 85.08 | 893,340 |
| 2024-08-23 | Conley Emily | Sale | 3,334 | 85.02 | 283,456 |
| 2024-08-23 | Conley Emily | Option Ex | 3,334 | 13.79 | 45,975 |
| 2024-08-23 | Miller Deborah Ann (Chief Legal Officer) | Sale | 11,000 | 85.04 | 935,440 |
| 2024-08-23 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 11,000 | 23.39 | 257,290 |
| 2024-08-08 | Miller Deborah Ann (Chief Legal Officer) | Sale | 3,000 | 68.01 | 204,042 |
| 2024-08-08 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 3,000 | 6.89 | 20,670 |
| 2024-07-29 | Shair Matthew | Sale | 2,000 | 80.33 | 160,660 |
| 2024-07-15 | Conley Emily | Sale | 5,000 | 80.76 | 403,815 |
| 2024-07-15 | Conley Emily | Option Ex | 5,000 | 13.79 | 68,950 |
| 2024-07-12 | Miller Deborah Ann (Chief Legal Officer) | Sale | 6,000 | 80.16 | 480,960 |
| 2024-07-12 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 6,000 | 27.85 | 167,100 |
| 2024-07-08 | Miller Deborah Ann (Chief Legal Officer) | Sale | 3,000 | 73.07 | 219,200 |
| 2024-07-08 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 3,000 | 6.89 | 20,670 |
| 2024-07-01 | Noci Darlene (Chief Development Officer) | Sale | 5,000 | 75.83 | 379,125 |
| 2024-07-01 | Noci Darlene (Chief Development Officer) | Option Ex | 5,000 | 18.93 | 94,650 |
| 2024-06-28 | Balcom Alexandra (Chief Financial Officer) | Sale | 10,000 | 76.02 | 760,230 |
| 2024-06-28 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 10,000 | 27.85 | 278,500 |
| 2024-06-24 | Shair Matthew | Sale | 2,000 | 80.32 | 160,634 |
| 2024-06-14 | Conley Emily | Sale | 5,000 | 77.92 | 389,575 |
| 2024-06-14 | Conley Emily | Option Ex | 5,000 | 13.79 | 68,950 |
| 2024-06-06 | Miller Deborah Ann (Chief Legal Officer) | Sale | 8,000 | 78.11 | 624,864 |
| 2024-06-06 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 8,000 | 12.91 | 103,280 |
| 2024-05-28 | Shair Matthew | Sale | 2,000 | 67.77 | 135,534 |
| 2024-05-15 | Conley Emily | Sale | 5,000 | 69.09 | 345,450 |
| 2024-05-15 | Conley Emily | Option Ex | 5,000 | 11.57 | 57,875 |
| 2024-05-13 | Shair Matthew | Sale | 37,500 | 66.13 | 2,479,987 |
Insider trading activities including stock purchases, stock sales, and option exercises of NUVL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nuvalent, Inc. (symbol NUVL, CIK number 1861560) see the Securities and Exchange Commission (SEC) website.